Statistical issues in pragmatic trials of behavioral economic interventions
نویسندگان
چکیده
منابع مشابه
Methodological issues in pragmatic trials of complex interventions in primary care.
distinction in trial design is made between explanatory (or efficacy) and pragmatic (or effectiveness) trials. 1 These terms, originally coined by Schwartz and Lellouch in 1967, are used to describe trials that either test causal research hypotheses to determine whether an intervention works in tightly controlled conditions to achieve optimal efficacy and/or to understand the key mechanism of a...
متن کاملProceedings of the University of Pennsylvania eighth annual conference on statistical issues in clinical trials: Statistical issues in pragmatic clinical trials.
This issue of Clinical Trials contains the proceedings of the eighth annual symposium on statistical issues in clinical trials held at the University of Pennsylvania in April 2015. This symposium considered special statistical issues in the design, conduct, and analysis of ‘‘pragmatic’’ clinical trials. Interest in pragmatic trials is rapidly increasing in recognition of the fact that many impo...
متن کاملStatistical issues in trials of preexposure prophylaxis
PURPOSE OF REVIEW We discuss selected statistical issues in the design and analysis of preexposure prophylaxis (PrEP) trials. The general principles may inform thinking for other interventions in HIV prevention. RECENT FINDINGS To date, four different designs have been used to determine the effectiveness of PrEP: randomized, double-blind, placebo-controlled; randomized, open-label, immediate ...
متن کاملTrials in primary care: statistical issues in the design, conduct and evaluation of complex interventions.
Trials carried out in primary care typically involve complex interventions that require considerable planning if they are to be implemented successfully. The role of the statistician in promoting both robust study design and appropriate statistical analysis is an important contribution to a multi-disciplinary primary care research group. Issues in the design of complex interventions have been a...
متن کاملStatistical/practical Issues in Clinical Trials
For approval of a drug product, the United States Food and Drug Administration (FDA) requires that substantial evidence of the effectiveness and safety of the drug product be provided through the conduct of two adequate, well-controlled clinical trials. To assist the sponsors in preparation of final clinical reports for regulatory submission and review, the FDA and other regulatory agencies and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Trials
سال: 2016
ISSN: 1740-7745,1740-7753
DOI: 10.1177/1740774516654862